NCT00265265View on ClinicalTrials.gov

Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2006

Conditions
Cocaine-Related Disorders
Interventions
DRUG

Atomoxetine

Trial Locations (1)

20814 4799

Uniformed Services University of Health Science, Bethesda

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00265265 - Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1 | Biotech Hunter | Biotech Hunter